通过分子对接,与IIS-路径相关的蛋白质发生安托西亚宁结合亲和和和非共价相互作用
Haroon1,2, Zahid Khan2, Wasim Javaid1
1College of Forestry and Landscape Architecture, South China Agricultural University, Guangzhou 510642, China.
Current issues in molecular biology
|February 25, 2025
概括
安西氨酸通过与胰岛素/胰岛素类生长因子信号通路中的关键蛋白质相互作用,表现出抗衰老和胰岛素敏感性作用. 分子对接显示出强大的结合,表明长寿和胰岛素抵抗的治疗潜力.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 氨酸是植物颜料,具有潜在的健康益处.
- 胰岛素/胰岛素类生长因子信号传递 (IIS) 途径对于衰老和新陈代谢至关重要.
- 了解小分子与IIS蛋白的相互作用是治疗开发的关键.
研究的目的:
- 为了研究抗衰老和胰岛素敏感性质的安东素.
- 为了阐明特定的安托西亚宁和IIS通路蛋白之间的分子相互作用.
- 评估分子对接对预测这些相互作用的实用性.
主要方法:
- 采用了in silico分子对接技术.
- 在Reticulitermes chinensis中分析了各种安东基安和关键的IIS蛋白 (Pdk1,EIF4E,Tsc2) 之间的结合亲缘关系.
- 计算预测被用来确定潜在的治疗机制.
主要成果:
- 在R. chinensis. 中观察到特定的安东和IIS通路蛋白 (Pdk1,EIF4E,Tsc2) 之间存在强烈的结合亲和关系.
- 这些相互作用表明,观察到的抗衰老和胰岛素敏感作用的分子机制.
- 分子对接在预测小分子与蛋白质相互作用方面被证明是有效的.
结论:
- 安西氨酸具有减轻胰岛素抵抗和促进长寿的显著潜力.
- 这项研究强调了安东的治疗前景和in silico方法的有效性.
- 需要进一步的体内和染色体分析来确认发现并探索生理学影响.
更多相关视频
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
2.3K
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.3K
相关概念视频
Protein-protein Interfaces
12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Ligand Binding and Linkage
4.7K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.7K
The Equilibrium Binding Constant and Binding Strength
12.8K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.8K
Ligand Binding Sites
12.7K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.7K
Drug-Receptor Bonds
2.7K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
2.7K
